中山大学附属第三医院的崔晨、陈泽宏等研究人员在《Cell Death Discovery》期刊上发表了题为 “TMEM45A enhances palbociclib resistance and cellular glycolysis by activating AKT/mTOR signaling pathway in HR+ breast ... CDK4/6 抑制剂耐药的患者至关重要。